Nathalie Laarakker
Director/Board Member bij OXURION NV
Profiel
Nathalie Laarakker is currently the Chief Financial Officer & Director at Intravacc BV since 2021.
She is also an Independent Non-Executive Director at Oxurion NV since 2023.
Previously, she held the position of Chief Financial Officer & Managing Director at Gadeta BV and Head-Finance at Merus NV.
Ms. Laarakker completed her undergraduate degree at the University of Amsterdam.
Actieve functies van Nathalie Laarakker
| Bedrijven | Functie | Begin |
|---|---|---|
| OXURION NV | Director/Board Member | 02-05-2023 |
| Intravacc BV | Director/Board Member | 01-01-2021 |
Eerdere bekende functies van Nathalie Laarakker
| Bedrijven | Functie | Einde |
|---|---|---|
| MERUS N.V. | Corporate Officer/Principal | - |
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Corporate Officer/Principal | - |
Opleiding van Nathalie Laarakker
| University of Amsterdam | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| OXURION NV | Health Technology |
| MERUS N.V. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Gadeta BV
Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Health Technology |
| Intravacc BV |
